Boston, MA 06/02/2014 (wallstreetpr) – A worldwide distinguished bio-pharmaceutical company, NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), on May 30, 2014, declared its support for World Hypoparathyroidism Awareness Day. The bio-medical company pioneers and provides therapies and treatments, which alter the lives of patients with unusual diseases. The company announced its support for the day by initiating a free of cost Emergency Resources Kit equipped to deliver appropriate and speedier diagnosis of the symptoms of Hypoparathyroidism in emergency care, as well as other therapeutic care settings.
The annual global observance of the World Hypoparathyroidism Awareness Day:
The annual international recognition of the Hypoparathyroidism day motivates people to enhance awareness of the disorder and its symptoms. In addition, observance of this important day also encourages people to be responsive of the necessity for more education, innovative treatment option and superior diagnosis.
Emergency Resources Kit:
The Hypoparathyroidism Emergency Resources Kit introduced by NPS includes a wallet card, an ID bracelet, along with a key chain tag, which point out that somebody is surviving with Hypoparathyroidism. When someone carries any of these indicators, care providers and patients might be able to make health caregivers to be vigilant when somebody is affected by Hypoparathyroidism symptoms. The indications associated with the disease include tetany (extreme cramping), seizures, spasms or cardiac problems that might create obscured airway. The kits are accessible freely and can be ordered from the NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) website.
Hypoparathyroidism:
The disease is an unusual disorder where the human body creates inadequate level of parathyroid hormones, the key regulator of important minerals as phosphorus and calcium. The widest spread cause of the disease is either injury to or deletion of the parathyroid glands during operations for any form of next surgery or thyroid cancer. However, it can also be genetic. Moreover, in few cases the causes are still unrevealed.
CEO commented:
The Chief Executive Officer and President of NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Francois Nader, MD stated that the pharmaceutical company is pleased to join the international Hypoparathyroidism community in observing the important day by enhancing the realization and awareness of this atypical, multifaceted endocrine disorder.
